RAUWILOID THERAPY IN ALCOHOLISM
Abstract
1. In a double-blind study with 2 mephenesin-like drugs, B and C, and placebos used as controls, Rauwiloid and Rauwidrine therapy proved effective for the psychogenic factors of chronic alcoholism.
2. Rauwiloid was most useful in relieving the symptoms of anxiety, nervousness and tension; supplementary therapy with Rauwidrine was usually effective when depression was a problem.
3. Sedation with Rauwiloid and Rauwidrine is notably free of toxic effects or habituation, offering a decided advantage over the use of barbiturates, bromides or other habit-forming drugs.
4. The use of Rauwiloid and Rauwidrine for the treatment of alcoholism, or other chronic states in which psychosomatic factors are prominent, merits further investigation.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
